Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

Stock Information for Dyadic International Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Dyadic International Inc.

Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
Dyadic to Report Second Quarter 2024 Financial Results on Tuesday, August 13, 2024
Dyadic to Attend Industry Events in June
Dyadic Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress
Dyadic to Attend Industry and Investor Events in May
Dyadic to Report First Quarter 2024 Financial Results on Tuesday, May 14, 2024
Dyadic Reports 2023 Full Year Results and Recent Company Progress
Dyadic Announces Change in Board and Management Leadership Roles

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.